Eladocagene exuparvovec
- Status:
- Red
- Decision Date:
- May 2023
Comments
RED: NICE HST26 - Treating aromatic L‑amino acid decarboxylase deficiency.
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again